Skip to main content
Log in

Breast cancer genetic evolution: I. Data from cytogenetics and DNA content

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

A general scheme of chromosome alterations occurring during tumor progression is proposed from the cytogenetic study of 113 breast carcinomas. For 76 of these tumors, chromosome numbers and rate of chromosome rearrangements were correlated with DNA content studied by flow cytometry. A series of 536 cases was used as control for flow cytometry. The following evolution can be proposed: 1. occurrence of unbalanced rearrangements decreasing chromosome number and DNA content; 2. correlatively to the rate of chromosome rearrangements, formation of endoreduplications leading to hyperploid sidelines; 3. persistence of the near diploid cells and decrease of chromosome number to about 35 and of DNA index to .85; 4. more frequently, elimination of the near diploid cells and complete passage to hyperploidy; 5. further losses of chromosomes in the hyperploid tumors, whose karyotypes can decrease to about 55 chromosomes and a DNA index of 1.35; 6. eventually, occurrence of a second endoreduplication, leading to an apparent near tetraploidy. The rate of rearranged chromosomes may reach 80% in both near diploid tumors with 35–40 and hyperploid tumors with 55–65 chromosomes which can be regarded as those with the highest degree of tumor progression. It is shown that the increase of chromosome number and DNA index above diploidy is very limited, and that all tumors with more than 50 chromosomes and 1.35 DNA content passed through endoreduplication. This results in many possible losses of heterozygosity in these cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ayraud N, Lambert JC, Hufferman-Tribollet K, Basteris B: Etude cytogénétique comparative de sept carcinomes d'origine mammaire. Ann Genet 20: 171–177, 1977

    PubMed  Google Scholar 

  2. Dutrillaux B, Gerbault-Seureau M, Zafrani B: Characterization of chromosomal anomalies in human breast cancer. Cancer Genet Cytogenet 49: 203–217, 1990

    PubMed  Google Scholar 

  3. Ferti-Passantonopoulou AD, Panami AD: Common cytogenetic findings in primary breast cancer. Cancer Genet Cytogenet 27: 289–298, 1987

    Article  PubMed  Google Scholar 

  4. Gerbault-Seureau M, Viehl P, Dutrillaux B: Recurrent HSR in the centromeric region of chromosome 8 in breast cancer. Ann Genet 30: 146–151, 1987

    PubMed  Google Scholar 

  5. Kovacs G: Preferential involvement of chromosome 1q in a primary breast carcinoma. Cancer Genet Cytogenet 3: 125–129, 1981

    Article  PubMed  Google Scholar 

  6. Rodgers CS, Hill SM, Hulten MA: Cytogenetic analysis in human breast carcinoma. I. Nine cases in diploid range investigated using direct preparations. Cancer Genet Cytogenet 13: 95–119, 1984

    PubMed  Google Scholar 

  7. Mitchell ELD, Santibanez-Koref MF: 1p13 is the most frequently involved band in structural chromosomal rearrangements in human breast cancer. Genes, Chromosomes & Cancer 2: 278–289, 1990

    Google Scholar 

  8. Remvikos Y, Gerbault-Seureau M, Viehl P, Zafrani B, Magdelenat H, Dutrillaux B: Relevance of DNA ploidy as a measure of genetic deviation: A comparison of flow cytometry and cytogenetics in 25 cases of human breast cancer. Cytometry 9: 612–618, 1988

    PubMed  Google Scholar 

  9. Vindelov L, Christensen I, Keiding N, Spang-Thomsen M, Nissen M: Long-term storage of samples for flow cytometric DNA analysis. Cytometry 5: 317–322, 1983

    Google Scholar 

  10. Remvikos Y, Beuzeboc P, Zajdela A, Voillemot M, Magdelenat H, Pouillart P: Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. J Natl Cancer Inst 81: 1383–1387, 1989

    PubMed  Google Scholar 

  11. Couturier J, Vielh P, Salmon RJ, Lombard M, Dutrillaux B: Chromosome imbalance in endometrial adenocarcinoma. Cancer Genet Cytogenet 33: 67–76, 1988

    Article  PubMed  Google Scholar 

  12. Muleris M, Salmon RJ, Dutrillaux B: Cytogenetics of endorectal adenocarcinomas. Cancer Genet Cytogenet 46: 143–156, 1990

    Article  PubMed  Google Scholar 

  13. Kallioniemi O, Blanco G, Alavaikko M, et al: Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. Cancer 62: 2183–2190, 1988

    PubMed  Google Scholar 

  14. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359–366, 1957

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dutrillaux, B., Gerbault-Seureau, M., Remvikos, Y. et al. Breast cancer genetic evolution: I. Data from cytogenetics and DNA content. Breast Cancer Res Tr 19, 245–255 (1991). https://doi.org/10.1007/BF01961161

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01961161

Key words

Navigation